hrcak mascot   Srce   HID

Periodicum biologorum, Vol.118 No.4 March 2017.

Review article
https://doi.org/10.18054/pb.v118i4.4576

Podocytes and the actin cytoskeleton as a feasible therapeutic target

Sanja Sever ; Harvard Medical School and Massachusetts General Hospital, Charlestown, MA
Changkyo Gu ; Harvard Medical School and Massachusetts General Hospital, Charlestown, MA

Fulltext: english, PDF (2 MB) pages 381-384 downloads: 240* cite
APA 6th Edition
Sever, S. & Gu, C. (2016). Podocytes and the actin cytoskeleton as a feasible therapeutic target. Periodicum biologorum, 118 (4), 381-384. https://doi.org/10.18054/pb.v118i4.4576
MLA 8th Edition
Sever, Sanja and Changkyo Gu. "Podocytes and the actin cytoskeleton as a feasible therapeutic target." Periodicum biologorum, vol. 118, no. 4, 2016, pp. 381-384. https://doi.org/10.18054/pb.v118i4.4576. Accessed 17 Nov. 2018.
Chicago 17th Edition
Sever, Sanja and Changkyo Gu. "Podocytes and the actin cytoskeleton as a feasible therapeutic target." Periodicum biologorum 118, no. 4 (2016): 381-384. https://doi.org/10.18054/pb.v118i4.4576
Harvard
Sever, S., and Gu, C. (2016). 'Podocytes and the actin cytoskeleton as a feasible therapeutic target', Periodicum biologorum, 118(4), pp. 381-384. doi: https://doi.org/10.18054/pb.v118i4.4576
Vancouver
Sever S, Gu C. Podocytes and the actin cytoskeleton as a feasible therapeutic target. Periodicum biologorum [Internet]. 2016 [cited 2018 November 17];118(4):381-384. doi: https://doi.org/10.18054/pb.v118i4.4576
IEEE
S. Sever and C. Gu, "Podocytes and the actin cytoskeleton as a feasible therapeutic target", Periodicum biologorum, vol.118, no. 4, pp. 381-384, 2016. [Online]. doi: https://doi.org/10.18054/pb.v118i4.4576

Abstracts
Podocyte injury is a hallmark of the glomerular disease, which is a direct cause of chronic kidney diseases. Importantly, podocyte injury is a consequence of the dysregulation of the actin cytoskeleton. In diverse animal models of proteinuric glomerular disease, recovering the integrity of the actin structure in podocytes resulted in beneficial effects. In this review, we focus on the premise of targeting the actin cytoskeleton as a feasible therapeutics for treating chronic kidney diseases

Hrčak ID: 177545

URI
https://hrcak.srce.hr/177545

Visits: 307 *